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Abstract
©  2016  by  The  American  Society  of  Hematology.Platelet-driven  blood  clot  contraction
(retraction)  is  thought  to  promote wound closure and secure hemostasis  while  preventing
vascular  occlusion.  Notwithstanding  its  importance,  clot  contraction  remains  a  poorly
understood process, partially because of the lack of methodology to quantify its dynamics and
requirements.  We used  a  novel  automated  optical  analyzer  to  continuously  track  in  vitro
changes in the size of contracting clots in whole blood and in variously reconstituted samples.
Kinetics  of  contraction  was  complemented  with  dynamic  rheometry  to  characterize  the
viscoelasticity  of  contracting  clots.  This  combined  approach  enabled  investigation  of  the
coordinated mechanistic impact of platelets, including nonmuscle my osin II, red blood cells
(RBCs), fibrin(ogen), factor XIIIa (FXIIIa), and thrombin on the kinetics and mechanics of the
contraction process. Clot contraction is composed of 3 sequential phases, each characterized by
a distinct rate constant. Thrombin, Ca2+, the integrin αIIbβ3, myosin IIa, FXIIIa cross-linking,
and platelet count all promote 1 or more phases of the clot contraction process. In contrast,
RBCs impair contraction and reduce elasticity, while increasing the overall contractile stress
generated by the platelet fibrin meshwork. A better understanding of the mechanisms by which
blood cells, fibrin(ogen), and platelet-fibrin interactions modulate clot contraction may generate
novel approaches to reveal and to manage thrombosis and hemostatic disorders.
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